This project is funded by the European Union
Increasing Prevention and Treatment of TB
This website has been produced with the assistance of the European Union. The content of this website is the sole responsibility of the ILULU partnership and can in no way be taken to reflect the views of the European Union.
Dr Katalin Wilkinson
Senior Investigator Scientist (MRC-UK)
IIDMM, University of Cape Town
Qualifications
MSc, PhD
Previous Roles
August 2004 - July 2007: Imperial College London, Research Associate, based at the University of Cape Town; understanding the protective and pathogenic immune response in HIV associated TB.
January 2002 - August 2004: Imperial College London, Research Assistant, investigating the human T cell response in tuberculosis, and the host and bacillary correlates of pathology in TB.
October 1999 - May 2001: University of Oxford, Research Assistant; Investigations of the human T cell response in TB using ELISPOT and flow cytometry techniques
September 1997 - September 1999: Case Western University, Cleveland, OH, Research Associate; modulation of TGF-beta gene expression by different cytokines.
March 1997 - August 1997: Medical Research Council UK, postdoctoral scientist; Human CD8 T cell response in TB; The immune response to M. leprae.
September 1993 - February 1997: Eotvos Lorand University Budapest, Hungary; PhD student; Localisation of T cell epitopes from the 16 kDa and 38 kDa proteins of Mycobacterium tuberculosis using synthetic peptides.
Role undertaking on EU TB diagnostics project
Katalin is a MRC (UK) Senior Investigator Scientist at the National Institute for Medical Research, Mill Hill, seconded to the University of Cape Town at the IIDMM. Her research focuses on the Immunology of HIV associated tuberculosis. Katalin’s role in the EU TB diagnostics project is supervisory, including training and advice on experimental techniques, experimental design, data analysis and interpretation. She will oversee all work in the Category 2+ Tissue Culture facility that handles blood from patients infected with blood borne viruses (HIV); regularly draw up SOP and RA documents; maintain and supervise a general good laboratory practice from all users.
Last updated: July 7th 2008